XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 84 shares, a drop of 72.7% from the May 14th total of 308 shares. Based on an average daily trading volume, of 1,762 shares, the days-to-cover ratio is currently 0.0 days.
XOMA Stock Performance
Shares of XOMA stock opened at $25.42 on Thursday. XOMA has a one year low of $25.14 and a one year high of $30.00. The firm has a fifty day moving average of $25.79 and a two-hundred day moving average of $26.12.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
See Also
- Five stocks we like better than XOMA
- 2 Ways to Play the QXO/TopBuild Deal
- Wolfspeed Ditches EV Woes for High-Margin Defense Jets
- Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
